ER71 directs mesodermal fate decisions during embryogenesis

ER71 directs mesodermal fate decisions during embryogenesis.

Er71 mutant embryos are nonviable and lack hematopoietic and endothelial lineages. To further define the functional role for ER71 in cell lineage decisions, we generated genetically modified mouse models. We engineered an Er71-EYFP transgenic mouse model by fusing the 3.9 kb Er71 promoter to the EYFP reporter gene. Using FACS and transcriptional profiling, we examined the EYFP(+) population of ...

Early events leading to fate decisions during leech embryogenesis.

This paper reviews leech development up to the 12-cell embryo. Oogenesis proceeds by a system of nurse cells that contribute to oocyte growth via continuous cytoplasmic connections. Development begins when fertilized eggs are deposited: formation of the polar bodies, and centration of the male and female pro-nuclei is accompanied by cytoskeletal contractions, and formation of teloplasm (yolk-fr...

Cell Fate Decisions During Breast Cancer Development

During the formation of breast cancer, many genes become altered as cells evolve progressively from normal to a pre-malignant to a malignant state of growth. How mutations in genes lead to specific subtypes of human breast cancer is only partially understood. Here we review how initial genetic or epigenetic alterations within mammary epithelial cells (MECs) can alter cell fate decisions and put...

Fate Decisions during Neural Crest Ontogeny

Recombination signal sequence-binding protein Jkappa alters mesodermal cell fate decisions by suppressing cardiomyogenesis.

The transcription factor recombination signal sequence-binding protein Jkappa (RBP-J) is a key downstream element in the signaling pathway of all four mammalian Notch receptors that are critically involved in the control of embryonic and adult development. RBP-J-deficient mice display complex defects and die around day 9.5 postcoitum. Here, we investigate the function of RBP-J in the developmen...